SOTERA HEALTH COMPANY Foreign Currency Transaction Gain (Loss), before Tax
SOTERA HEALTH COMPANY (SHC) reported Foreign Currency Transaction Gain (Loss), before Tax of $3.75 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-08-06
- SOTERA HEALTH COMPANY foreign currency transaction gain (loss), before tax for the quarter ending 2026-06-30 was $3.75M.
- SOTERA HEALTH COMPANY foreign currency transaction gain (loss), before tax for the quarter ending 2026-03-31 was $571.00K.
- SOTERA HEALTH COMPANY foreign currency transaction gain (loss), before tax for the quarter ending 2025-12-31 was -$1.56M.
- SOTERA HEALTH COMPANY foreign currency transaction gain (loss), before tax for the quarter ending 2025-09-30 was $1.53M, a 44.97% increase year-over-year.
- SOTERA HEALTH COMPANY foreign currency transaction gain (loss), before tax for fiscal 2025 was -$947.00K.
- SOTERA HEALTH COMPANY foreign currency transaction gain (loss), before tax for fiscal 2024 was -$199.00K.
- SOTERA HEALTH COMPANY foreign currency transaction gain (loss), before tax for fiscal 2023 was -$159.00K.
- SOTERA HEALTH COMPANY foreign currency transaction gain (loss), before tax for fiscal 2022 was -$145.00K.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.75M 10-Q · filed 2026-08-06 | $4.32M 10-Q · filed 2026-08-06 | $2.76M derived: sum of 3 quarters · filed 2026-08-06 | $4.29M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $571.00K 10-Q · filed 2026-05-05 | -$988.00K derived: sum of 2 quarters · filed 2026-05-05 | $540.00K derived: sum of 3 quarters · filed 2026-05-05 | -$87.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$1.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$31.00K derived: sum of 2 quarters · filed 2026-02-24 | -$658.00K derived: sum of 3 quarters · filed 2026-08-06 | -$947.00K 10-K · filed 2026-02-24 |
| 2025-09-30 | $1.53M 10-Q · filed 2025-11-04 | $901.00K derived: sum of 2 quarters · filed 2026-08-06 | $612.00K 10-Q · filed 2025-11-04 | -$1.82M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$627.00K 10-Q · filed 2026-08-06 | -$916.00K 10-Q · filed 2026-08-06 | -$3.35M derived: sum of 3 quarters · filed 2026-08-06 | -$2.30M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$289.00K 10-Q · filed 2026-05-05 | -$2.73M derived: sum of 2 quarters · filed 2026-05-05 | -$1.67M derived: sum of 3 quarters · filed 2026-05-05 | -$1.06M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$2.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$1.38M derived: sum of 2 quarters · filed 2026-02-24 | -$771.00K derived: sum of 3 quarters · filed 2026-02-24 | -$199.00K 10-K · filed 2026-02-24 |
| 2024-09-30 | $1.05M 10-Q · filed 2025-11-04 | $1.67M derived: sum of 2 quarters · filed 2025-11-04 | $2.24M 10-Q · filed 2025-11-04 | $2.46M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $611.00K 10-Q · filed 2025-08-08 | $1.18M 10-Q · filed 2025-08-08 | $1.41M derived: sum of 3 quarters · filed 2026-02-24 | $1.84M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $572.00K 10-Q · filed 2025-05-01 | $799.00K derived: sum of 2 quarters · filed 2026-02-24 | $1.23M derived: sum of 3 quarters · filed 2026-02-24 | $760.00K derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $227.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $653.00K derived: sum of 2 quarters · filed 2026-02-24 | $188.00K derived: sum of 3 quarters · filed 2026-02-24 | -$159.00K 10-K · filed 2026-02-24 |
| 2023-09-30 | $426.00K 10-Q · filed 2024-11-05 | -$39.00K derived: sum of 2 quarters · filed 2024-11-05 | -$386.00K 10-Q · filed 2024-11-05 | -$1.03M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$465.00K 10-Q · filed 2024-08-05 | -$812.00K 10-Q · filed 2024-08-05 | -$1.46M derived: sum of 3 quarters · filed 2025-02-27 | -$924.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$347.00K 10-Q · filed 2024-05-02 | -$994.00K derived: sum of 2 quarters · filed 2025-02-27 | -$459.00K derived: sum of 3 quarters · filed 2025-02-27 | $296.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$647.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$112.00K derived: sum of 2 quarters · filed 2025-02-27 | $643.00K derived: sum of 3 quarters · filed 2025-02-27 | -$145.00K 10-K · filed 2025-02-27 |
| 2022-09-30 | $535.00K 10-Q · filed 2023-11-01 | $1.29M derived: sum of 2 quarters · filed 2023-11-01 | $502.00K 10-Q · filed 2023-11-01 | $567.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $755.00K 10-Q · filed 2023-08-03 | -$33.00K 10-Q · filed 2023-08-03 | $32.00K derived: sum of 3 quarters · filed 2024-02-27 | -$724.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | -$788.00K 10-Q · filed 2023-05-03 | -$723.00K derived: sum of 2 quarters · filed 2024-02-27 | -$1.48M derived: sum of 3 quarters · filed 2024-02-27 | -$1.55M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $65.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$691.00K derived: sum of 2 quarters · filed 2024-02-27 | -$767.00K derived: sum of 3 quarters · filed 2024-02-27 | -$1.34M 10-K · filed 2024-02-27 |
| 2021-09-30 | -$756.00K 10-Q · filed 2022-11-02 | -$832.00K derived: sum of 2 quarters · filed 2022-11-02 | -$1.41M 10-Q · filed 2022-11-02 | -$1.55M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$76.00K 10-Q · filed 2022-08-04 | -$654.00K 10-Q · filed 2022-08-04 | -$794.00K derived: sum of 3 quarters · filed 2023-02-28 | $3.78M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$578.00K 10-Q · filed 2022-05-05 | -$718.00K derived: sum of 2 quarters · filed 2023-02-28 | $3.85M derived: sum of 3 quarters · filed 2023-02-28 | $4.03M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$140.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $4.43M derived: sum of 2 quarters · filed 2023-02-28 | $4.60M derived: sum of 3 quarters · filed 2023-02-28 | $5.23M 10-K · filed 2023-02-28 |
| 2020-09-30 | $4.57M 10-Q · filed 2021-11-10 | $4.74M derived: sum of 2 quarters · filed 2021-11-10 | $5.37M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $172.00K 10-Q · filed 2021-08-12 | $799.00K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $627.00K 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | -$3.86M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |